(XNPT:Consolidated Issue Listed on NASDAQ Global Select )
Jeryl L. Hilleman M.B.A
Independent Director and Chairman of Audit Committee, Xenoport, Inc.
|Age||Total Calculated Compensation||This person is connected to 8 board members in 1 different organizations across 5 different industries.|
See Board Relationships
Ms. Jeryl L. Hilleman, also known as Jeri, MBA has been the Chief Financial Officer of Intersect ENT Inc. since June 04, 2014 and also serves as its Principal Accounting Officer. Ms. Hilleman served as the Chief Financial Officer and Secretary of Ocera Therapeutics, Inc. from September 3, 2013 to June 3, 2014 and as its Principal Accounting Officer since December 11, 2013. Ms. Hilleman served as the Chief Financial Officer of Amyris, Inc., (formerly, Amyris Biotechnologies, ...
3410 Central ExpresswayPhone: 408-616-7200
Santa Clara, California 95051
Board Members Memberships*
Independent Director and Chairman of Audit Committee
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Kevin A. Lobo||Chairman, Chief Executive Officer and President|
|Olivier Bohuon||Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination & Governance Committee |
Smith & Nephew plc
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Hiroyuki Sasa||President and Representative Director|
|¥100.0M||Compensation as of Fiscal Year 2014.|